Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $19.20 Analyst target: $22.25 Upside: 15.89%
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. The company is headquartered in Redwood City, California.
See the full interactive analysis & chart →Informational only — not investment advice.